• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. Apr 1995; 39(4): 839–845.
PMCID: PMC162639

Quantitation of slow drug release from an implantable and degradable gentamicin conjugate by in vivo magnetic resonance imaging.

Abstract

A biodegradable model hydrogel containing a covalently bound aminoglycoside in which drug release can be monitored by magnetic resonance imaging (MRI) in vivo was developed. The hydrogel consists of the bishydroxysuccinimide ester of polyethylene glycol disuccinate cross-linked albumin, to which gentamicin and Gd-diethylenetriaminepentaacetic acid are covalently attached in stochiometric quantities. MRI allowed us to depict the three-dimensional structure of implanted gels, to accurately calculate their volumes, and thus to calculate the concentration of hydrogel-bound gentamicin. The correlation coefficient for the concentration of released gentamicin and the hydrogel volume was 0.965. Free and hydrogel-released gentamicin conjugates had similar antibiotic efficacies when tested in microbiological agar diffusion assays. In vivo, hydrogel-released gentamicin had a longer half-life in plasma than unaltered gentamicin (5.6 versus 0.7 h), presumably because of residual bound polyethylene glycol residues. Hydrogel implants into rats resulted in a prolonged (7 to 10 days) release of gentamicin and a decreased 24-h mortality in mice infected with a lethal dose of Pseudomonas aeruginosa. The results indicate the feasibility of imaging and quantitating therapeutic drug concentrations in vivo by MRI.

Full Text

The Full Text of this article is available as a PDF (426K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem. 1977 Jun 10;252(11):3578–3581. [PubMed]
  • Baker RW, Ferrett J. Estimation of polyethyleneglycols in human urine for studies of intestinal absorption. J Chromatogr. 1983 Apr 8;273(2):421–425. [PubMed]
  • Boyce ST, Supp AP, Warden GD, Holder IA. Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds. Antimicrob Agents Chemother. 1993 Sep;37(9):1890–1895. [PMC free article] [PubMed]
  • Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol. 1984 May;2(5):498–504. [PubMed]
  • Craig WA. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J Antimicrob Chemother. 1993 May;31 (Suppl 500):149–158. [PubMed]
  • Drusano GL. Human pharmacodynamics of beta-lactams, aminoglycosides and their combination. Scand J Infect Dis Suppl. 1990;74:235–248. [PubMed]
  • Ford CW, Hamel JC, Stapert D, Yancey RJ. Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. J Med Microbiol. 1989 Apr;28(4):259–266. [PubMed]
  • Fujimoto S, Miyazaki M, Endoh F, Takahashi O, Okui K, Morimoto Y. Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. Cancer. 1985 Nov 15;56(10):2404–2410. [PubMed]
  • Gerber AU. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections. Scand J Infect Dis Suppl. 1990;74:147–154. [PubMed]
  • Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med. 1994 May;31(5):567–571. [PubMed]
  • Hnatowich DJ, Childs RL, Lanteigne D, Najafi A. The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J Immunol Methods. 1983 Dec 16;65(1-2):147–157. [PubMed]
  • Hutchinson FG, Furr BJ. Biodegradable polymers for controlled release of peptides and proteins. Horiz Biochem Biophys. 1989;9:111–129. [PubMed]
  • Juni K, Ogata J, Matsui N, Kubota M, Nakano M. Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives. Chem Pharm Bull (Tokyo) 1985 Apr;33(4):1734–1738. [PubMed]
  • Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm Res. 1992 Mar;9(3):283–290. [PubMed]
  • Kramer PA. Letter: Albumin microspheres as vehicles for achieving specificity in drug delivery. J Pharm Sci. 1974 Oct;63(10):1646–1647. [PubMed]
  • Lee JW, Amantea MA, Francis PA, Navarro EE, Bacher J, Pizzo PA, Walsh TJ. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob Agents Chemother. 1994 Apr;38(4):713–718. [PMC free article] [PubMed]
  • Weissleder R, Bogdanov A, Frank H, Nossiff N, Bogdanova A, Schaffer BK, Brady T, Wittenberg J. AUR Memorial Award 1993. A drug system (PDH) for interventional radiology. Synthesis, properties, and efficacy. Invest Radiol. 1993 Dec;28(12):1083–1089. [PubMed]
  • Weissleder R, Saini S, Stark DD, Elizondo G, Compton C, Wittenberg J, Ferrucci JT., Jr Pyogenic liver abscess: contrast-enhanced MR imaging in rats. AJR Am J Roentgenol. 1988 Jan;150(1):115–120. [PubMed]
  • Yoshioka T, Ikeuchi K, Hashida M, Muranishi S, Sezaki H. Prolonged release of bleomycin from parenteral gelatin sphere-in-oil-in-water multiple emulsion. Chem Pharm Bull (Tokyo) 1982 Apr;30(4):1408–1415. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...